The synergy was also observed in CCNE1-amplified HCC1569 cells indicating that combined dosing may afford an attractive therapeutic strategy for CCNE1-amplified tumours (Fig. 4f, Extended Data Fig. 8f). This evidence concerns the gene CCNE1 and neoplasm.